Arbutus Biopharma Corp Payments for (Proceeds from) Investments
Arbutus Biopharma Corp (ABUS) reported Payments for (Proceeds from) Investments of $24.37 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromInvestments · last filed 2020-05-11
- Arbutus Biopharma Corp payments for (proceeds from) investments for the quarter ending 2020-03-31 was $24.37M, a 7196.11% increase year-over-year.
- Arbutus Biopharma Corp payments for (proceeds from) investments for the quarter ending 2019-09-30 was $0.00.
- Arbutus Biopharma Corp payments for (proceeds from) investments for the quarter ending 2019-06-30 was $0.00.
- Arbutus Biopharma Corp payments for (proceeds from) investments for the quarter ending 2019-03-31 was $334.00K, a 99.56% decline year-over-year.
- Arbutus Biopharma Corp payments for (proceeds from) investments for fiscal 2018 was $3.01M.
- Arbutus Biopharma Corp payments for (proceeds from) investments for fiscal 2017 was -$35.09M, a 142.50% decline from fiscal 2016.
- Arbutus Biopharma Corp payments for (proceeds from) investments for fiscal 2016 was $82.55M.
- Arbutus Biopharma Corp payments for (proceeds from) investments for fiscal 2015 was -$9.64M, a 122.97% decline from fiscal 2014.
| Period end | Payments for (Proceeds from) Investments 3 month | Payments for (Proceeds from) Investments 3 month as first filed | Payments for (Proceeds from) Investments 6 month | Payments for (Proceeds from) Investments 9 month | Payments for (Proceeds from) Investments 12 month |
|---|---|---|---|---|---|
| 2020-03-31 | $24.37M 10-Q · filed 2020-05-11 | ||||
| 2019-09-30 | $0.00 10-Q · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $0.00 10-Q · filed 2019-11-06 | -$44.68M derived: sum of 4 quarters · filed 2020-05-11 | |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-05 | $0.00 10-Q · filed 2019-08-05 | -$44.68M derived: sum of 3 quarters · filed 2020-05-11 | -$44.68M derived: sum of 4 quarters · filed 2020-05-11 | |
| 2019-03-31 | $334.00K 10-Q · filed 2020-05-11 | $0.00 10-Q · filed 2019-05-06 | -$44.68M derived: sum of 2 quarters · filed 2020-05-11 | -$44.68M derived: sum of 3 quarters · filed 2020-05-11 | -$44.68M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | -$45.01M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$45.01M derived: sum of 2 quarters · filed 2019-11-06 | -$45.01M derived: sum of 3 quarters · filed 2019-11-06 | $3.01M 10-K · filed 2019-03-07 | |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-06 | -$24.59M 10-Q · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $48.02M 10-Q · filed 2019-11-06 | $74.52M derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-05 | -$15.40M 10-Q · filed 2018-08-03 | $60.02M 10-Q · filed 2019-08-05 | $74.52M derived: sum of 3 quarters · filed 2019-08-05 | $68.68M derived: sum of 4 quarters · filed 2019-08-05 |
| 2018-03-31 | $75.42M 10-Q · filed 2019-05-06 | $74.52M derived: sum of 2 quarters · filed 2019-05-06 | $68.68M derived: sum of 3 quarters · filed 2019-05-06 | $66.95M derived: sum of 4 quarters · filed 2019-05-06 | |
| 2017-12-31 | -$894.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$6.74M derived: sum of 2 quarters · filed 2019-03-07 | -$8.47M derived: sum of 3 quarters · filed 2019-03-07 | -$35.09M 10-K · filed 2019-03-07 | |
| 2017-09-30 | -$5.84M 10-Q · filed 2018-11-07 | -$7.57M derived: sum of 2 quarters · filed 2018-11-07 | -$34.19M 10-Q · filed 2018-11-07 | -$50.10M derived: sum of 4 quarters · filed 2018-11-07 | |
| 2017-06-30 | -$1.73M 10-Q · filed 2018-08-03 | -$28.35M 10-Q · filed 2018-08-03 | -$44.26M derived: sum of 3 quarters · filed 2018-08-03 | -$43.54M derived: sum of 4 quarters · filed 2018-08-03 | |
| 2017-03-31 | -$26.62M 10-Q · filed 2018-05-04 | -$42.52M derived: sum of 2 quarters · filed 2018-05-04 | -$41.81M derived: sum of 3 quarters · filed 2018-05-04 | $42.63M derived: sum of 4 quarters · filed 2018-05-04 | |
| 2016-12-31 | -$15.91M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$15.19M derived: sum of 2 quarters · filed 2018-03-16 | $69.25M derived: sum of 3 quarters · filed 2018-03-16 | $82.55M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $712.00K 10-Q · filed 2017-11-02 | $85.15M derived: sum of 2 quarters · filed 2017-11-02 | $98.46M 10-Q · filed 2017-11-02 | $99.09M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-06-30 | $84.44M 10-Q · filed 2017-08-03 | $97.75M 10-Q · filed 2017-08-03 | $98.38M derived: sum of 3 quarters · filed 2018-03-16 | $115.52M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-03-31 | $13.31M 10-Q · filed 2017-05-04 | $13.94M derived: sum of 2 quarters · filed 2018-03-16 | $31.08M derived: sum of 3 quarters · filed 2018-03-16 | $41.02M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2015-12-31 | $630.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $17.77M derived: sum of 2 quarters · filed 2018-03-16 | $27.72M derived: sum of 3 quarters · filed 2018-03-16 | -$9.64M 10-K · filed 2018-03-16 | |
| 2015-09-30 | $17.14M 10-Q · filed 2016-11-03 | $27.09M derived: sum of 2 quarters · filed 2016-11-03 | -$10.28M 10-Q · filed 2016-11-03 | -$11.58M derived: sum of 4 quarters · filed 2017-03-22 | |
| 2015-06-30 | $9.94M 10-Q · filed 2016-08-04 | -$27.42M 10-Q · filed 2016-08-04 | -$28.72M derived: sum of 3 quarters · filed 2017-03-22 | -$28.43M derived: sum of 4 quarters · filed 2017-03-22 | |
| 2015-03-31 | -$37.36M 10-Q · filed 2016-05-04 | -$38.66M derived: sum of 2 quarters · filed 2017-03-22 | -$38.37M derived: sum of 3 quarters · filed 2017-03-22 | $4.62M derived: sum of 4 quarters · filed 2017-03-22 | |
| 2014-12-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | -$1.01M derived: sum of 2 quarters · filed 2017-03-22 | $41.98M derived: sum of 3 quarters · filed 2017-03-22 | $41.98M 10-K · filed 2017-03-22 | |
| 2014-09-30 | $291.00K 10-Q · filed 2015-11-05 | $43.28M derived: sum of 2 quarters · filed 2015-11-05 | $43.28M 10-Q · filed 2015-11-05 | ||
| 2014-06-30 | $42.99M 10-Q · filed 2015-08-07 | $42.99M 10-Q · filed 2015-08-07 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |